Deuterium isotope effects in the metabolism of n-alkylsubstituted amphetamines in man by Vree, T.B. et al.






The following full text is a publisher's version.
 
 





Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
Reprinted from
C lin ic a  C h im ica  A cta
Elsevier Publishing Company, Amsterdam - Printed in The Netherlands
DEUTERIUM  ISOTOPE EFFECTS IN THE METABOLISM OF 
iV-ALKYLSUBSTITU TED AMPHETAMINES IN MAN
T. B. V REE, J. P. M. C. GORGELS, A. TH. J. M. MUSKENS a n d  J. M. VAN  ROSSUM 
Catholic University o f Nijmegen, Department o f Pharmacology,
Geert Groote P lein  N  21, Nijmegen ( The Netherlands)
SUMMARY
Deuterium isotope effects in the metabolism of deuterated amphetamine and 
iV-substituted deuterated amphetamines were studied in man. The isotope effect is 
large when in the elimination process of the amphetamine from the body, the metabol- 
ic processes, deamination and iV-dealkylation are the major pathways and the renal 
excretion is the minor one. It appeared to be probable, that in the deamination and 
N-dealkylation process the tertiary hydrogen atom is of importance.
INTRODUCTION
Within a series of iV-alkyl substituted amphetamines it has been observed that 
the larger alkyl groups are more easily removed (iV-dealkylation) than the smaller 
groups; i.e. isopropyl > ethyl > methyl. As a result of this dealkylation, amphetamine 
itself becomes the metabolite. Examination of the ratio of unaltered compound/ 
amphetamine metabolite, when the excretion is maximal, indicates a fixed ratio 
between the two substances. These ratios are: 6 for methylamphetamine, 2 for ethyl- 
amphetamine and 0.6 for isopropylamphetamine. Within the same series, we are 
dealing with the energy difference of the C-H bond between the primary H of the
*
methylgroup, secondary H of the ethylgroup and tertiary H of the isopropyl group. 
Whereas the dextro-isomers show the above decrease in ratio of compound/metabolite 
excreted, the levo-isomers show no change from one system to another, with all com- 
pounds exhibiting the same fixed ratio of 10:1. The physico-chemical parameters 
(e.g pKa, lipid solubility) of both isomers (d\-l)  show only small differences, whereas 
the levo-isomer show no stimulant properties and are metabolized to a much lesser 
extent, indicating a sterical preference both for the stimulus receptor system andto the 
metabolizing enzyme system2-12.
Metabolic clearance of amphetamine derivatives involves three pathways: 
parahydroxylation, deamination and iV-dealkylation. Dring6»7 has reported that, in 
man, the parahydroxylation is about 1-2%  when the urinary excretion rate of the 
amphetamines is maximal. In view of the preceeding statement, itm ay be assumed that 
the metabolic clearance due to parahydroxylation is negligible and that the overall 
elimination of amphetamines is due to excretion of unaltered compound, deamination
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Fig. i. Elimination pathways of amphetamine, phentermine and the deuterated amphetamines.
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and dealkylation. We may therefore assume that the sum of the unaltered amphet- 
aminè excreted, plus deaminated and dealkylated product is equivalent to 100% of 
the ingested dose.
In this manner, the percentage of deaminated amphetamine, found after 
excretion of 70% unaltered compound, is 30%. (see Fig. 1). Similar results are found 
when amphetamine and phentermine are compared. When these compounds are 
simultaneously administered to the same person, 100% of the phentermine and 70% 
of the amphetamine is excreted unaltered. The total amount of amphetamine excreted 
is dependent upon the ratio of metabolic and renal clearance constants, km resp. kr 
which in turn are dependent upon the physico-chemical parameters of both the am­
phetamine and the enzyme system12. Since from each amount of amphetamine ab- 
sorbëd or metabolically formed, 70% is excreted unaltered when amphetamine is a 
metabolite of some administered compound, the percentages of excretion, deamina- 
tion and dealkylation of the original compound may be calculated12 (see Table I).
Phenylethylamine is excreted only 1-5%  unaltered. Comparison of this result 
to that of amphetamine plus its derivatives suggests that the deaminating enzyme is 
hindered when the aliphatic side chain is branched and/or that the deamination re- 
quires a hydrogen atom. If the deamination did not require the presence of a proton,.
T A B L E  I
Compound %  Deamination %  Dealkylation %  Excretion * kr km
4-'amphetamine ’ '' 30 — 70 kr >■ km
+  methylamphetamine 20 15 65 kr >  km
+  ethylamphetamine 3° 30 40 kr — km
+  isopropylamphetamine 45 45 10 kj <  km
•+ dimethylamphetamihe 10 5° 40 kr =  km
amphetamine : 10 — 90 kr >  km
— methylamphetamine 10 10 80 kj >  km
— ethylamphetamine 0 10 90 kp km
/—s isopropy lamphétanii ne 0 15 85 kr >  km
r^ r dimethylamphetamine xo 20 80 kr >  km
* %  of iftgested dose, kr renal clearance constant, km metabolic clearance constant.
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then we would have expected some deamination of the phentermine. Since the latter 
is excreted essentially unchanged, it may initially be assumed that the hydrogen atom 
is of importance. The purpose of this investigation therefore was to determine the 
importance of the alkyl hydrogen with respect to dealkylation and deamination and 
whether its abstraction was the rate limiting step.
When proton abstraction (C-H bond rupture) is believed to be the rate limiting 
step in the reaction sequence between a particular molecule and an enzyme system, 
the use of deuterium in place of hydrogen at the suspected position of proton ab­
straction may demonstrate the validity of the hypothesis; that is to say, if a deuterium 
isotope effect can be demonstrated, the corresponding C-H bond exerts a determining 
role with respect to the rate limiting step1-1'10’11. In accordance with this, the hydrogen 
atom in question was replaced by a deuterium atom. The occurrence of a primary 
deuterium effect indicates a slower rate of C-D bond rupture compared to C-H bond 
rupture.
R E SU LTS
The resuits obtained give clear evidence as to the involvement of the tertiary 
hydrogen in both the Ar-dealkylating and deaminating sequence. It should be recog- 
nized that, in the human body, several elimination mechanisms may mask a small 
deuterium effect.
The excretion rate, of the unaltered compound, which is maintained constant 
and maximal by maintaining the urine acidic, can be of importance. For example, 
when the hydrogen compound is excreted 50% unaltered and the deuterium com­
pound is excreted 50.5% unaltered, the conclusions resulting from the cumulative 
excretion, may be that there is no isotope effect, whereas many observations may show 
a statistical significant effect. Other factors, such as the partition volume and the 
excretion rate of the deuterium and hydrogen compound may be different. The parti­
tion volumes and the excretion rates both depend upon the pK a value of the com­
pound and this vaJue may difïer maximal 0.05 between the 2 compounds5 Table II. 
The deuterated compounds are more ionized than the hydrogen compounds at the pH 
of the blood (7.40) Since the nonionized form of amphetamine is reabsorbed in the 
renal tubulus, the deuterated compounds are, or can be, more rapidly excreted than 
the hydrogen compounds. If the lather is true then the difference in excretion rate 
must be constant during the whole period of excretion and the deuterium content 
of the urine samples must gradually decrease.
TABLE II
Drug p K a
Amphetamine 9.83 ± O.OI
Deuteroamphetamine 9.88 ± O.OI
Methylamphetamine 9.90 ± 0.02
Trideuteromethylamphetamine 9-95 ± 0.02
Isopropylamphetamine 10.31 ± O.OI
Deuteroisopropylamphetamine 10.36 ± O.OI
Deuteroisopropyldeuteroamphetamine 10.38 ± O.OI
Dimethylamphetamine 9-97 ± O.OI
Di-trideuteromethylamphetamine 10.08 ± O.OI
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The retention time of the compounds on the Apiezon-KOH column reflects the 
lipid solubility of the compounds. The deuterium compounds tend to decrease the 
retention time and due to this observation it is unlikely that the lipid solubility and the 
related partition volume have increased.
When one is dealing with a deuterium effect in the metabolism, (iV-deamination 
or the iV-dealkylation), the enzymatic proces must be slower for the deuterium 
compound due to the higher force constant of the C-D bond. Therefore, the gradualin- 
crease in the deuterium content to the hydrogen content in the urine at subsequent 
time intervals will be less, or even a decrease may be found.
In our study a continuous increase of the percentage deuterium in the samples 
was found indicating a necessary manifestation of the deuterium effect in the metabo­
lism. The observation that the deuterated compound is excreted totally to a higher 
extent is secondary and is caused by factors other than the difference in metabolism. 
The increase of the percentage deuterium of the samples may be a large one, for 
instance with deuteroisopropylamphetamine or a small one, as with deuteroamphet- 
amine.
(~r) deuterated amphetamine vs. (-\-) amphetamine (Table III) (Fig. 2).
Observation of the deuterium percentage of amphetamine in the first urine 
sample after ingestiön of both compounds (50% H, 50% D), and the deuterium content 
in one of the last urine samples (48 h) indicates an appropiate increase of 15%  (Accuracy 
of thë det’ennination is ±  2%).
TABLE III ’
D IF F E R E N C E S  IN  E X C R E T IO N  A N D  M E T A B O L ISM  O F D E U T E R O A M P H E T A M IN E  A N D  A M P H E T A M IN E  ( + )
Subject D osis % D  dosis % D  stari % D  end % H  excr. % D  excr. % excr. % p H
J .G /i 12 mg 50.8 45 60 79 68.9 IO.I 15 5
F.H. 10 mg 50.1 5° 68 71.9 90 18.1 18 5
F.H .. 12 mg 50.4 53 62 70.7 88.4 17.7 9 5-&
H.F.s ' 12 mg 5° ° 54 01 54 75-3 20.3 7 5-7
■ From this data it can be concluded that there is a small deuterium effect. The 
composition of deuterium and hydrogen compound in the first urine samples deter- 
Mnes >the total cumulative excretion data. Foreman8 has shown with deuterated am­
phetamine a distinct deuterium effect with respect to metabolism by homogenized 
rabbit liver. The rabbit and human metabolize amphetamine in the same way, but 
from Table I it can be seen that when the renal excretion kr is more important than 
the metabolic clearance km, the deuterium effect measured is small.
TA B LE IV
D IF F E R E N C E S  IN  M E T A B O L ISM  A N D  E X C R E T IO N  B E T W E E N  ( +  ) M E T H Y L A M P H E T A M IN E  A N D  ( +  ) T R ID E U T E R O - 
M E T H Y L  A M P H E T A M IN E
Subject D osis % D  dosis % D  start % D  end % H  excr. % D  excr. % excr. % p H
W.V. 7.7 mg 50.1 54 54 69 88 19 0 5
L.S. 7.° mg 50.0 55 55 74 90 16 0 5
J.G. 7-5 mg 50.2 56 56 61.3 75-7 14.4 0 5
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Fig. 2. Renal excretion rate, urine pH, urine production and cumulative excretion of dextro- 
amphetamine and dextro-deuteroamphetamine. The deuterium content of the urine samples 
shifted from 50% in the first urine samples to 60% in the last ones (Table III). The difierence 
in excretion rate between D- and H-amphetamine is small, due to the fact that the renal clearance 
of the unaltered compound is much more important than the metabolic clearance (Table I).
( + )  trideuteromethylamphetamine vs. (~\~) methylamphetamine (Table IV)
W ith methylamphetamine, the deuterium content of the urine samples varies 
between 52 and 56% throughout the total period and essentially tliere is no shift in 
the percentage deuterium. The total amount of trideuteromethylamphetamine 
excreted is higher than the amount of methylamphetamine excreted.
C.C.A. Special issue 14
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Fig. 3, Renal excretion rate, urine pH, urine production and cumulative renal excretion of dextro- 
deuteroisopropylamphetamineand dextro-isopropylamphetamine. Thereis a remarkable deuterium 
efiect, whichs begins 10 h after ingestion of the compounds.
- di-trideuteromethylampheiamine vs. (-{-) dimethylamphetamine (Table V)
: ïDipiethylamphetamine does not show a deuterium effect in the iV-dealkj’lation 
of the nrst and second methylgroup. The deuterium content of the urine samples 
varies but no deuterium shift is observed.
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TABI.E V
D IF F E R E N C E S  IN  M E T A B O L ISM  A N D  E X C .R E TIO N  B E T W E E N  ( +  ) D IM E T H Y L A M P H E T A M IN E  A N D  ( +  ) D IT R I- 
D E U T E R O M E T H Y L A M P H E T A M IN E
Subject D osis % D  dosis % D  start % D  end % H  txcr. % D  excr. A %  excr. A % p H
J.G. 20 mg 50.1 50 60 18 27 9 10 5
J-B. 21 mg 50.0 50 61 18 24 6 11 5
j.H . 14.6 mg 50-1 50 57 6 9 3 7 5
M.H. 13.8 mg 50.2 59 60 17 25 8 1 5
(— ) dimethylamphetamine and (—) ditrideu terom ethyl amphetam ine.
8M.H. 15 mg 50.0 55 55 18 26 0 5
The accuracy in %I> by means of raassfragmentometry is ±  5%.
TA B LE  VI
D IF F E R E N C E S  IN  M3 T A B O I.IS M  A N D  E X C R E T IO N  B E T W E E N  ( + )  IS O P R O P Y L A M P H E T A M IN E  A N D  ( +  ) D E U T E R O -
IS O P R O P Y L A M P H E T A M IN E
jpiij'ect D osis % D  dosis % D  start % D  end % H  excr. % D  excr. A  % excr. A % p H
T.V. 13 mg 50.0 48 90 13-7 14.2 0-5 4 2 *| 5
J.G. 15 ™g 49-5 4« 89 8-35 9.90 1-55 41 • 5
J.S. 15-ï mg 49-5 48 82 8-75 10.X4 1-39 . 34 5
J.G. r5 mg 50.0 48 90 5-o 6.50 i-5° 42 5
C.V. 15 mg 500 48 80 12.1 12.4 0.30 32 5
(— ) isopropylamphetamine and !; - ) deuteroisopropylamphetamine
J.S. 15 mg 50.0 51 5 i 63.2 63-5 0.30 0 5
P.R. 16 mg 521 55 53 57-3 66.5 9.2 0 5
J.G. 17 mg 52.0 52 53 54-o 56.8 2.8 0 5
TA B LE  VII
D IF F E R E N C E S  IN  M E IA B O U S M  A N D  E X C R E T IO N  B E T W E E N  ( +  ) IS O P R O P Y L A M P H E T A M IN E  A N D  D E U T E R O - 
IS O P R O P Y L -D E U T E R O A M P H E T A M IN E
Subject Dosts % D  dosis % D  start % D  end % H  excr. % D  excr. A %  excr. A % p H
C.V. 44.1 mg 49-5 50 80 7-95 6.02 1-93 3° 5
T.V. 43.0 mg 50.0 45 75 3-14 2.04 I.IO 3° 5
J-B. 42-3 mg 51-3 40 77 1.70 1-25 o-45 37 5
(— ) isopropylamphetamine and (— ) deuteroisopropyldeuteroamphetamine.
F.H. 41.6 mg 50.0 52 54 88 76 12 2 5
H.H. 4°-4  mg 50.1 51 52 82 80 2 1 5
(-{-) deuteroisopropylamphetamine vs. (-{-) isopropylamphetamine (Table VI) (Fig. 3) 
This compound elicits a rather large difference between the hydrogen and 
deuterium compound. The deuterium content increases from 48% to 90% in all the 
subjects, but in some subjects the deuterium shift begins or is measurable only xo h 
after ingestion. When the urine is acidic, (pH 5) the total amount of isopropylamphet- 
amine excreted in the first 10 h determined the total cumulative excretion and for this 
reason the differences between deuterium and hydrogen cumulative excretion are very 
small, in spite of the great deuterium shift. The dextro-isomer shows this effect, but 
the levo-isomer does not. From Table I it can be seen that for the dextro-isomer the 
metabolic processes of elimination are much more important than the renal excretion 
and that with levo-isopropylamphetamine the relationship between renal and me­
tabolic clearance is reversed.
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Fig. 4. Renal excretion rate, urine pH, urine production and cumulative renal excretion of dextro 
deuteroiscpropyldeuteroamphetamine and aextroisoprcpylamphetamine. There is a deuterium- 
effect of the same magnitude as mentioned in Fig. 3.
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( + )  deuteroisopropyl-deuteroamphetaminevs. isopropylamphetamine (TableVYl) (Fig. 4) 
According to the results with deuteroisopropylamphetamine it was expected 
that the halflife time of deuteroisopropyldeuteroamphetamine would be doubled. 
The experiments, on the contrary, do not show a further increase in T  1/2 of the 
dideuteroisopropylamphetamine. The reason for this may possibly be the following: 
The purpose of the experiments was to prove that both tertiary hydrogen atoms 
in isopropylamphetamine are chemically identical for the enzyme. Therefore they 
were replaced by deuterium atoms in order to show that the hydrogen atoms in ques- 
tion are involved and are rate limiting. We have compared H-isopropyl-with D- 
isopropylamphetamine and found an increase in T 1/2 from 2 h to 4 h for the deuterium 
compound. From above experiments 2 hypotheses may follow:
Hypothesis I. The enzymes deaminate and dealkylate the H- and D-iso- 
propylamphetamine with the same affinity, thus, the difference in excretion rate and 
T  1/2 is caused by the C-D bond rupture.
♦ Hypothesis I I .  The enzyme can perform one öietabolic aótiori with the compound and af ter that action the compound leaves the enzyme action site.
If both dealkylation and deamination occurred at the same time, ,no amphet­
amine would be found as metabolite. When two different enzymes are involved, then 
the dideuterated isopropylaifiphetamine must be metabolized at a slower rkte than 
the monodeuterated isopropylamphetamine. When we are comparing -isopropyt- 
amphetamine with the dideuteroisopropylamphetamine and.take into account hypo­
thesis II, then it does not matter whether the C-D bond óf- the amphetaminemoiety is 
broken or the C-D bond of the isopropyl moiety is broken. When the isopropyl group 
has been removed, the metabolite shows the normal deuterium effect. 1 1 ■
EXPERIMENTS ■ .v. "i
Synthesis
Deuterated dextro- and levo-amphetamine were synthesized according to 
Foreman8. The rotations of the d- and Z-deuterated amphetamine found were! 
(a) =  +29.0° C =  1.995 in water (rf-tartrate salt) and (a.)fj’ =  — 28.0° C =  2.005 
water (i-tartrate salt).
Di-trideuteromethylamphetamine. 0.01 mole of rf-amphetamine was treated with 
0.1 mole deuterated formic acid and 0.05 mole of trideuteroformaldehyde. The reaction 
^ P w a s followed by means of gas chromatography-mass spectrometry. Completion of 
reaction was evidenced by disappearance of the basepeak at 72 (H-dimethylamphe- 
tamine) and the appearance of. the base peak 78 (D-dimethylamphetamine). The 
levo isomer was prepared in a similar manner.
Trideuteromethylamphetamine. 500 mg of the di-trideuteromethylamphetamine 
was oxidized by a tenfold excess of an alkaline permanganate solution and the reaction 
was followed by GLC-MS until the ditrideuteromethylamphetamine disappeared.
Deuteroisopropylamphetamine. 2 g of ^-amphetamine were refluxed with 150 ml 
of acetone and 5 g of anhydrous magnesium sulphate. The reaction was followed 
gaschromatographically. The acetone was removed by. vacuum and to the concen- 
trated Schiff base 3 ml of D20  and sufficiënt sodiumborodeuteride were added in small 
portions underreflux. The reduction wasfollowed continuouslyby GLC-MS andstopped 
when the base peak of the Schiff base in the mass spectrum (m =  84) had dissappeared.
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The mass spectrum of the deuteroisopropylamphetamine showed a base peak at 
m =  87. The levo isomer was prepared in the same way.
Deuteroisopropyl-deuteroamphetamine. 1 g  of ^-deuteroamphetamine is refluxed 
with 150 ml of acetone and 5 g of ahydrous magnesiumsulphate. Due to the magne- 
siumsulphate the yield of the reaction is quantitative.
The excess of acetone is removed under vacuum and sodiumborodeuteride and 
DaO was added in small portions. The reduction was followed by GLC-mass spectro- 
metry.
Fuli details of the reactions will be published elsewhere13.
METHODS
Apparatus
Gaschromatograph H P 402 with flame ionisation detection. Glass column, 1.80 
m, 3 mm diameter, filled with 20% Apiezon L 5%  KOH Diatoport-S-6o-8o mesh. Oven 
temperature 160°, temperature injection block 200° and temperature detector b lo ck ™  
220°. Nitrogen flow 30 ml/min, hydrogen flow 40 ml/min and air flow 300 ml/min.
Gaschromatograph-massspectrometer LK B  9000.
Glass column 1.20 m, 3 mm diameter, filled with 20% Apiezon L  5% KOH 
Diatoport-S-6o-8o mesh. Oven temperature 140°, injection block 200° separator 220° 
and ion source temperature 250°.
Ionisation energy 70 eV, trapcurrent 60 mA, accelerating voltage 3.5 kV.
Detection methods
The concentration of the amphetamines in the urine of the subjects was 
measured by means of the gaschromatographic analysis with the intemal Standard 
method. The same samples were injected into the L K B  9000 system in order to de- 
termine the percentage of deuterium of the sample.
Determinations
Mixtures of equal amounts of amphetamine and deuterated amphetamine were 
ingested as HC1 salts by male subjects (Table III-VII).
The urine was kept acidic, pH 5.0 ±  0.2, by the ingestion of 1.6 g of ammonium- 
chloride four times a day. Each amount of urine was collected for 60 h or until such 
time that the excretion rate w as 1 %  of the maximum excretion rate. The pH of t h e ^  
urine sample was measured upon receipt with a Copenhagen Radiometer. The average 
urine production was measured and the curves of average renal excretion rate were 
constructed. To 10 ml of the urine, 10 fj,g of the intemal Standard iV-methyl benzyl- 
amine was added and the solution made alkaline to pH 13 with KOH pellets. Then 
the alkaline solution was extracted twice with 10 ml of freshly distilled ether, the 
combined ether layers extracted with 5 ml 2 N  HC1. The acidic layer was made al­
kaline to pH 13 and extracted twice with 10 ml of ether. The combined ether layers 
were evaporated under a mild stream of dry air until 100 fjl remained. was
injected into the gaschromatograph HP 402 and into the L K B  9000.
Detection methods
In order to be able to determine the ratio of deuterated-non deuterated amphet- 
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amine in a mixture of these compounds, we used the mass spectrum of this mixture, 
taking the ratio of the base peaks as a measure for the ratio of concentrations in the 
mixture. A calibration curve was made using mixtures of D- and H-amphetamines of 
known composition. The masses examined were: amphetamine-deuteroamphet- 
amine, line intensities m/e+44-45 methylamphetamine-trideuteromethylamphetamine, 
line intensities m/e+ 58-61 isopropylamphetamine-deuteroisopropylamphetamine, 
line intensities m/e+ 86-87 isopropylamphetamine-deuteroisopropyldeuteroamphet- 
amine, hne intensities m/e+ 86-88 dimethylamphetamine-ditrideuteromethylamphet- 
amine, mass fragmentometry ratio of peak areas of the masses 72 and 78.
For the calibration curves, line intensities at various concentrations in the 
gaschromatographic peak were measured. The average ratio of the line intensities 
was used. This method is allowed when the retention times of the H- and D-amphet- 
amine are equal. When there is a differencein retention time, as is the case with dimethyl- 
amphetamine, the method of mass fragmentometry9 must be followed. For the 
other compounds both methods are followed but give the same calibration curve. The 
accuracy of the estimation of the percentage deuterium in the samples is ± 2% .
An example of a calibration curve is given in Fig. 5. : ' r
100% hydrogen 0 %  hydrog-en
Fig- 5- Calibration curve of percentage deuteriumisopropylamphetamine and the ratio of line 
intensities of the base peaks m/e+ =  86 and m/e+ =  87.
Determination of p K a value of some amines by means of second differential titration
curves
pH measurements were carried out with Radiometer equipment, consisting of 
a pH meter type PHM 26, equipped with a scale expander, a glass electröde type G 202 
B combined with a calomel electröde, type K  401. The system was calibrated using 
Standard buffers: for iso-pH-adjustment: 0.025 M  K H 2P0 4 (3.40225 g/i) and 0.025 
M N a aHP0 4 • H20  12 (8.95210 g/1) yieldings: 15° pH 6.900
20° pH 6.881 
250 pH 6.865
tilin. Chim. Acta, 34 (1971) 333~344
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for electrode sensitivity adjustment: 0.05 M KHphtalate (10.21150 g/1) with 
pH =  3.999 at 150 
4.002 at 20°
4.008 at 25°
The titration vessel was thermostated at 22° and contained about 4 ml solution. 
The titrant was carbonate free KOH o.100 N  (Titrisol, Merck). A  microburette (max. 
volume 5 ml) was connected with a fine capillary, dipping into the solution. The plun- 
ger type burette had a accuracy of about 0.1% per 1 ml titrant. The solution was stir- 
red with a magnetic stirrer and kept under nitrogen. 0.1 mmole of the amine HCI salt 
was dissolved. The end point of the titration was determined by differentiating the 
pH curve and taking dapH/dV2 in which V is the added volume titrant. The pKa 
value was determined by interpolating in the pH curve.
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